Both in Pharmaceuticals
Kardigan vs Nektar Therapeutics
Over the past year KARD returned −27.3% and NKTR returned −45.4%; their daily moves had a correlation of 0.29.
KARD −27.3% NKTR −45.4%Growth of $1, one year, split-adjusted
| Metric | KARD | NKTR |
|---|---|---|
| Price | $13.47 | $38.07 |
| Market cap | $1.26B | $1.30B |
| Today | −0.96% | +0.26% |
| 1 month | −8.1% | −35.7% |
| 6 months | — | −54.2% |
| Year to date | — | −10.0% |
| 1 year | — | −39.2% |
| Revenue growth (YoY) | — | −9.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −401.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 23.8× |
| Net cash | $597.6M | $684.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 69.7% |
| Short % of float | 13.8% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).